Overview

Biomarkers to Enhance Early Schizophrenia Treatment

Status:
NOT_YET_RECRUITING
Trial end date:
2030-07-30
Target enrollment:
Participant gender:
Summary
This study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better to certain medications that are used to treat people with psychosis.
Phase:
PHASE4
Details
Lead Sponsor:
Northwell Health
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Aripiprazole
Clozapine
Risperidone